School of Medicine
Showing 291-300 of 5,185 Results
-
Fiona Barwick, PhD, DBSM
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
Current Research and Scholarly InterestsResearch interests focus on expanding sleep education, improving sleep health, optimizing treatment for circadian rhythm disorders, and adapting treatment for insomnia in populations where developmental, medical, psychiatric and cultural factors intersect.
Current research projects include developing and piloting integrated protocols for treating sleep problems that co-occur with medical conditions such as chronic pain or POTS. Ongoing collaborations include delivery of a CBTI protocol in Mandarin via telehealth to patients at Chongqing Traditional Chinese Medicine Hospital in China. Past projects include investigation of the link between RLS and the gut microbiome and a survey of student sleep health. -
Preetha Basaviah, M.D.
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMedical education, preparation for clerkship curricula and hospital medicine.
-
Marina Basina
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Current Research and Scholarly InterestsDiabetes type I and type II, insulin pump therapy, glucose sensor technology, insulin resistance, PCOS, thyroid disorders
-
Dorsey Bass
Associate Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsOur laboratory is interested in the pathophysiology, immunology, and epidemiology of viral gastroenteritis.
-
Hannah Bassett
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsUnderstanding how to implement real time patient-centered healthcare cost transparency in the acute care setting and how this transparency effects patient and system-level outcomes.
Understanding how to best decrease unnecessary variation in clinical care through implementation of clinical effectiveness tools. -
Michael Bassik
Associate Professor of Genetics
Current Research and Scholarly InterestsWe are an interdisciplinary lab focused on two major areas:(1) we seek to understand mechanisms of cancer growth and drug resistance in order to find new therapeutic targets(2) we study mechanisms by which macrophages and other cells take up diverse materials by endocytosis and phagocytosis; these substrates range from bacteria, viruses, and cancer cells to drugs and protein toxins. To accomplish these goals, we develop and use new technologies for high-throughput functional genomics.
-
Pamela A. Basto
Instructor, Medicine - Oncology
BioDr. Basto is a physician scientist and medical oncologist specializing in the diagnosis and treatment of gastrointestinal malignancies.
She attended The University of Texas graduating magna cum laude in biomedical engineering, subsequently gaining her Ph.D. in Medical Engineering and Medical Physics at the Harvard-MIT Health Science and Technology program under the tutelage of Professors Robert Langer and Ulrich von Andrian at the Koch Institute for Integrative Cancer Research. Her thesis focused on developing next generation polymeric nanoparticle vaccines towards improved antigen specific cellular and humoral responses, work that has been translated into clinical trials. She completed medical school at Stanford University, followed by residency in internal medicine at The Mount Sinai Hospital in the ABIM research pathway, where she served on the ICU frontlines during the COVID-alpha wave at Elmhurst Hospital. She subsequently completed her hematology/oncology fellowship at Stanford University training in Professor Edgar Engleman’s lab in tumor immunology. Her translational research studies how cancers metastasize leveraging the immune system and designing therapeutics to interrupt this cascade. She was clinically trained by Professor Lipika Goyal in clinical and trial management of patients with hepatopancreatobiliary cancers.
As a clinician, she aims to create a welcoming partnership with patients during a difficult diagnosis based in trust and science, supported by an excellent clinical team. She welcomes patients from all backgrounds and aims to honor their values in culture, religion, and gender preferences. Her approach is to offer evidence based knowledge and the latest available treatments, including clinical trials, personalized to each individual’s tumor biology and their values.
